No Data
Anges, Helios and others [Emerging Markets Press Release]
The Singapore branch of Riskier has been established. A joint research contract has been signed with Stanford Universities in the USA regarding the development of a new cancer treatment through genome editing by Anges. The results of the joint research on the nasal administration formulation of the improved DNA Vaccine are available. Regarding Helios, the status of the conditional and time-limited approval application for ARDS treatment drugs in Japan is ongoing, and discussions on the development and sales partnership agreement with Nobel Pharma have been concluded.
Key points of attention for the 15th PTS = Digital HD, Takamiya, Reskill.
▽ Digital HD <2389.T>, recognition of extraordinary income ▽ Takamiya <2445.T>, signed a basic agreement for acquiring stocks of Nikken Lease (subsidiarization) ▽ Reskill <291A.T>, opening a branch in Singapore ▽ Helios <4593.T>, discussions concluded regarding the development and sales partnership agreement with Nobel Pharma ▽ S Shower <4838.T>, "100% Hits! Space Shower TV Plus" broadcasts ended ▽ Kose <4922.T>, acted towards Fox Tail.
Emerging Markets outlook: Attention may turn towards lightly traded ultra-low-priced stocks and biotech-related stocks.
■ Emerging Markets are left out of the investment choices. This week, Emerging Markets declined. During the same period, the Nikkei average fell by -1.95%, while the Growth Market Index fell by -2.67%, and the Growth Market 250 Index fell by -3.09%, indicating that Emerging Markets were relatively weaker. As attention turns to the central bank meetings in Japan and the United States, reports of Nissan <7201> and Honda <7267> beginning discussions on a management integration have redirected interest towards auto stocks and Auto Parts suppliers in the Main Board, leaving Emerging Markets out of the investment picture.
Express News | [Large Shareholding Report] Mr. Wataru Matsuda reported a 72.4% Shareholding in Reskill (291A.JP).
The Tokyo Stock Exchange Growth Index has rebounded, staying in positive territory but with limited gains.
TSE Growth Market Index 815.81 +0.92 / Volume 0.2 billion 30.7 million shares / Trading value 131.1 billion yen TSE Growth Market 250 Index 635.85 +0.41 / Volume 0.1 billion 9.36 million shares / Trading value 95.6 billion yen Today's growth market saw a rebound in both the TSE Growth Market Index and the TSE Growth Market 250 Index, with 251 stocks increasing, 308 stocks decreasing, and 38 unchanged. The growth market today experienced a heavy upper range.
[IPOs] Reskill --- The initial price is 4,840 yen (offering price 3,730 yen)
The initial price of Riskil <291A> was 4,840 yen, exceeding the public offering price by 29.8%. The Volume at the time of the initial price formation was 0.37 million shares.